IL128768A0 - Transdermal therapeutic system containing oestriol - Google Patents

Transdermal therapeutic system containing oestriol

Info

Publication number
IL128768A0
IL128768A0 IL12876897A IL12876897A IL128768A0 IL 128768 A0 IL128768 A0 IL 128768A0 IL 12876897 A IL12876897 A IL 12876897A IL 12876897 A IL12876897 A IL 12876897A IL 128768 A0 IL128768 A0 IL 128768A0
Authority
IL
Israel
Prior art keywords
oestriol
system containing
therapeutic system
transdermal therapeutic
transdermal
Prior art date
Application number
IL12876897A
Other languages
English (en)
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of IL128768A0 publication Critical patent/IL128768A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/665Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
IL12876897A 1996-09-04 1997-08-13 Transdermal therapeutic system containing oestriol IL128768A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19635883A DE19635883A1 (de) 1996-09-04 1996-09-04 Transdermales therapeutisches System mit einer Östriol enthaltenden Wirkstoffkombination
PCT/EP1997/004392 WO1998009631A1 (de) 1996-09-04 1997-08-13 Transdermales therapeutisches system mit einer östriol enthaltenden wirkstoffkombination

Publications (1)

Publication Number Publication Date
IL128768A0 true IL128768A0 (en) 2000-01-31

Family

ID=7804611

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12876897A IL128768A0 (en) 1996-09-04 1997-08-13 Transdermal therapeutic system containing oestriol

Country Status (17)

Country Link
EP (1) EP0927036B9 (no)
JP (1) JP2000517324A (no)
KR (1) KR20010029451A (no)
CN (1) CN1228702A (no)
AT (1) ATE289818T1 (no)
AU (1) AU729898B2 (no)
CA (1) CA2261655A1 (no)
CZ (1) CZ70099A3 (no)
DE (2) DE19635883A1 (no)
ES (1) ES2239362T3 (no)
IL (1) IL128768A0 (no)
NO (1) NO991047L (no)
NZ (1) NZ334443A (no)
PL (1) PL332035A1 (no)
SK (1) SK25299A3 (no)
WO (1) WO1998009631A1 (no)
ZA (1) ZA977895B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100266670A1 (en) 2007-12-10 2010-10-21 Akira Yamamoto Transdermally absorptive preparation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
HU215124B (hu) * 1991-02-26 1998-09-28 Norwich Eaton Pharmaceuticals, Inc. Eljárás csontritkulás (osteoporosis) kezelésére szolgáló ösztrogént és difoszfonátot tartalmazó, szinergetikus hatású gyógyszerkészítmények előállítására
CA2131822C (en) * 1992-03-21 2002-12-17 Walter Elger Use of estriol for treating climacteric osteoporosis
JPH0679002A (ja) * 1993-12-14 1994-03-22 Hisamitsu Pharmaceut Co Inc 経皮投与用パッチシステム
DE4405898A1 (de) * 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide

Also Published As

Publication number Publication date
ATE289818T1 (de) 2005-03-15
EP0927036A1 (de) 1999-07-07
ZA977895B (en) 1998-03-02
AU729898B2 (en) 2001-02-15
SK25299A3 (en) 2000-08-14
JP2000517324A (ja) 2000-12-26
KR20010029451A (ko) 2001-04-06
DE19635883A1 (de) 1998-03-05
ES2239362T3 (es) 2005-09-16
EP0927036B1 (de) 2005-03-02
NO991047D0 (no) 1999-03-03
AU4015097A (en) 1998-03-26
CZ70099A3 (cs) 1999-07-14
CA2261655A1 (en) 1998-03-12
NO991047L (no) 1999-03-03
CN1228702A (zh) 1999-09-15
PL332035A1 (en) 1999-08-16
EP0927036B9 (de) 2005-08-10
NZ334443A (en) 1999-08-30
WO1998009631A1 (de) 1998-03-12
DE59712215D1 (de) 2005-04-07

Similar Documents

Publication Publication Date Title
EA199900553A1 (ru) Чрескожная терапевтическая система
AU676826B2 (en) Transdermal therapeutic systems
AU5825898A (en) Combined massage, acupressure and biomagnetic therapy apparatus
AP9801392A0 (en) Concentrated antibody preparation.
NO941593D0 (no)
HK1026378A1 (en) Syringe serving also as an ampoule and syringe forcollecting blood.
AU1917788A (en) Estradiol transdermal delivery system
AU8970198A (en) N,n-bis (phenylcarbamoylmethyl) dimethylammonium chloride and derivatives in thetreatment of pain
AU8093487A (en) Improvement in bromphenriamine, pseudoephedrine therapy
IL132115A0 (en) Drug preparations for treating sexual dysfunction
EP0679402A3 (en) Hybrid gel that secretes a biologically active substance.
MX9701968A (es) Emplasto de escopolamina.
ATE275966T1 (de) Activin stimulator enthaltende pharmazeutische zusammensetzung
HUP0003480A3 (en) Transdermal therapeutic system containing the active substance scopolamine base
IL128768A0 (en) Transdermal therapeutic system containing oestriol
ZA200007111B (en) Methods and devices for providing prolonged drug therapy.
AU7071487A (en) Chlorpheniramine therapy
AU5554598A (en) Use of endothelin conjugates in therapy, new endothelin conjugates, substances containing them, and processes for producing them
AU3039789A (en) Active substance for treating changes in the skin and mucous membranes
EP0190860A3 (en) 6-chloro-3-methyl-1h-2,3,4,5-tetrahydro-3-benzazepine-n-oxide and medical compositions using it
ES2141044A1 (es) Terapia con oxibutinina.
ZA966083B (en) Agent for transdermal administration containing esters of 13-ethyl-17ß-hydroxy-11-methylene-18,19-dinor-17Ó-pregn-4-en-20-yn-3-one.
GR3032072T3 (en) Transdermal therapeutical system for silatran compounds
SI1011674T1 (en) Transdermal therapeutic system containing the active substance scopolamine base
MX9709013A (es) Forma de dosis que comprende oxibutinina.